Clinical Trial Update: Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial updating on depletion of serum amyloid P component to enhance immune response to DNA vaccination in HIV patients; phases 1 and 2 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: University College, London | Conditions: HIV | Phase 1, Phase 2 | Status: COMPLETED